Chinese Journal of Dermatology ›› 2026, Vol. 59 ›› Issue (10): 935-947.doi: 10.35541/cjd.20260087
• Guidelines and Consensus • Previous Articles Next Articles
Chinese Society of Dermatology; China Dermatologist Association; Chinese Preventive Medicine Association Professional Committee on Prevention and Control of Dermatology and Sexually Transmitted Diseases
Received:2026-02-11
Revised:2026-09-10
Online:2026-10-15
Published:2026-10-07
Contact:
Zhou Pingyu; Xu Jinhua; Wang Qianqiu
E-mail:zpyls@yahoo.com
Supported by:Chinese Society of Dermatology, China Dermatologist Association, Chinese Preventive Medicine Association Professional Committee on Prevention and Control of Dermatology and Sexually Transmitted Diseases. Chinese guidelines for the diagnosis and treatment of neurosyphilis (2026 edition)[J]. Chinese Journal of Dermatology, 2026, 59(10): 935-947.doi:10.35541/cjd.20260087
| [1] | Yang Y, Gu X, Zhu L, et al. Clinical spectrum of late symptomatic neurosyphilis in China: an 11⁃year retrospective study[J]. Sex Transm Infect, 2024,100(8):477⁃483. DOI: 10. 1136/sextrans⁃2024⁃056117. |
| [2] | Gu X, Gao Y, Yan Y, et al. The importance of proper and prompt treatment of ocular syphilis: a lesson from permanent vision loss in 52 eyes[J]. J Eur Acad Dermatol Venereol, 2020,34(7):1569⁃1578. DOI: 10.1111/jdv.16347. |
| [3] | Zhou J, Zhang H, Tang K, et al. An updated review of recent advances in neurosyphilis[J]. Front Med (Lausanne), 2022,9:800383. DOI: 10.3389/fmed.2022.800383. |
| [4] | Shi M, Peng RR, Gao Z, et al. Risk profiles of neurosyphilis in HIV⁃negative patients with primary, secondary and latent syphilis: implications for clinical intervention[J]. J Eur Acad Dermatol Venereol, 2016,30(4):659⁃666. DOI: 10.1111/jdv. 13514. |
| [5] | 中国医师协会皮肤科医师分会性传播疾病专业委员会. 梅毒血清固定临床管理专家共识(2023)[J]. 中华皮肤科杂志, 2023,56(5):383⁃388. DOI: 10.35541/cjd.20220656. |
| [6] | Klein M, Angstwurm K, Esser S, et al. German guidelines on the diagnosis and treatment of neurosyphilis[J]. Neurol Res Pract, 2020,2:33. DOI: 10.1186/s42466⁃020⁃00081⁃1. |
| [7] | Centers For Disease Control And Prevention. Sexually transmitted infections treatment guidelines, 2021[EB/OL].(2021⁃07⁃23)[2024⁃10⁃27]. https://www.cdc.gov/std/treatment⁃guidelines/STI⁃Guidelines⁃2021.pdf. |
| [8] | 王千秋, 刘全忠, 徐金华, 等. 性传播疾病临床诊疗与防治指南[M]. 2版.上海: 上海科学技术出版社, 2020:78⁃100. |
| [9] | Zhu L, Gu X, Peng RR, et al. Comparison of the cerebrospinal fluid (CSF) toluidine red unheated serum test and the CSF rapid plasma reagin test with the CSF venereal disease research laboratory test for diagnosis of neurosyphilis among HIV⁃negative syphilis patients in China[J]. J Clin Microbiol, 2014,52(3):736⁃740. DOI: 10.1128/JCM.02522⁃13. |
| [10] | Guarner J, Jost H, Pillay A, et al. Evaluation of treponemal serum tests performed on cerebrospinal fluid for diagnosis of neurosyphilis[J]. Am J Clin Pathol, 2015,143(4):479⁃484. DOI: 10.1309/AJCPWSL3G8RXMCQR. |
| [11] | Callado GY, Pardo I, Gutfreund MC, et al. Insights into treatment alternatives for neurosyphilis: systematic literature review and meta⁃analysis[J]. Sex Transm Dis, 2024,51(10):641⁃647. DOI: 10.1097/OLQ.0000000000001983. |
| [12] | Marra CM, Ghanem KG. Centers for Disease Control and Prevention Syphilis Summit: difficult clinical and patient management issues[J]. Sex Transm Dis, 2018,45(9S):S10⁃S12. DOI: 10.1097/OLQ.0000000000000851. |
| [13] | Tuddenham S, Ghanem KG. Neurosyphilis: knowledge gaps and controversies[J]. Sex Transm Dis, 2018,45(3):147⁃151. DOI: 10.1097/OLQ.0000000000000723. |
| [14] | Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting, and evaluation in health care[J]. Prev Med, 2010,51(5):421⁃424. DOI: 10.1016/j.ypmed.2010.08.005. |
| [15] | WHO. WHO handbook for guideline development[M]. 2nd ed. Geneva: WHO, 2014:1⁃13,15⁃22. |
| [16] | Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations[J]. BMJ, 2008,336(7650):924⁃926. DOI: 10.1136/bmj.39489.470347.AD. |
| [17] | Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. introduction⁃GRADE evidence profiles and summary of findings tables[J]. J Clin Epidemiol, 2011,64(4):383⁃394. DOI: 10. 1016/j.jclinepi.2010.04.026. |
| [18] | Yang N, Liu H, Zhao W, et al. Development of the Scientific, Transparent and Applicable Rankings (STAR) tool for clinical practice guidelines[J]. Chin Med J (Engl), 2023,136(12):1430⁃1438. DOI: 10.1097/CM9.0000000000002713. |
| [19] | Diamond IR, Grant RC, Feldman BM, et al. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies[J]. J Clin Epidemiol, 2014,67(4):401⁃409. DOI: 10.1016/j.jclinepi.2013.12.002. |
| [20] | O'Leary PA, Cole HN, Moore JE, et al. Cooperative clinical studies in the treatment of syphilis: asymptomatic neurosyphilis[J]. Arch Derm Syphilol, 1937, 35(3):387⁃401. DOI: 10.1001/archderm.1937.01470210013002. |
| [21] | Ramachandran PS, Baird RW, Markey P, et al. Neurosyphilis: still prevalent and overlooked in an at risk population[J]. PLoS One, 2020,15(10):e0238617. DOI: 10.1371/journal.pone.0238617. |
| [22] | Solaimalai D, Gupta A, George L, et al. Upward trends of syphilis in the non⁃pregnant adults: a six⁃year report on clinical and epidemiological profile of syphilis from a tertiary care center, India[J]. Front Public Health, 2022,10:908591. DOI: 10.3389/fpubh.2022.908591. |
| [23] | Farahani M, Killian R, Reid GA, et al. Prevalence of syphilis among adults and adolescents in five sub⁃Saharan African countries: findings from Population⁃based HIV Impact Assessment surveys[J]. Lancet Glob Health, 2024,12(9):e1413⁃e1423. DOI: 10.1016/S2214⁃109X(24)00234⁃1. |
| [24] | Du FZ, Zhang HN, Li JJ, et al. Neurosyphilis in China: a systematic review of cases from 2009-2021[J]. Front Med (Lausanne), 2022,9:894841. DOI: 10.3389/fmed.2022.894841. |
| [25] | 陈泽伟, 梁诗晴, 岳晓丽, 等. 2010—2023年中国梅毒流行趋势及时空分布特征[J]. 中华皮肤科杂志, 2024,57(11):1045⁃1050. DOI: 10.35541/cjd.20240073. |
| [26] | Tang W, Huang S, Chen L, et al. Late Neurosyphilis and tertiary syphilis in Guangdong Province, China: results from a cross⁃sectional study[J]. Sci Rep, 2017,7:45339. DOI: 10.1038/srep45339. |
| [27] | Arns B, Vieceli T, Gomes E, et al. Risk factors for neurosyphilis in HIV patients: a retrospective cohort study[J]. Braz J Infect Dis, 2025,29(3):104519. DOI: 10.1016/j.bjid.2025.104519. |
| [28] | Lithgow KV, Church B, Gomez A, et al. Identification of the neuroinvasive pathogen host target, LamR, as an endothelial receptor for the Treponema pallidum adhesin Tp0751[J]. mSphere, 2020,5(2):e00195⁃20. DOI: 10.1128/mSphere.00195⁃20. |
| [29] | Daza⁃Ovalle JF, Ramirez⁃Penuela JA, Ramirez⁃Castro D, et al. Stroke in the setting of neurosyphilis: a comprehensive literature review[J]. Neurohospitalist, 2026,16(1):50⁃60. DOI: 10.1177/19418744251355654. |
| [30] | Wang C, Zhu L, Gao Z, et al. Increased interleukin⁃17 in peripheral blood and cerebrospinal fluid of neurosyphilis patients[J]. PLoS Negl Trop Dis, 2014,8(7):e3004. DOI: 10.1371/journal.pntd.0003004. |
| [31] | Radolf JD, Deka RK, Anand A, et al. Treponema pallidum, the syphilis spirochete: making a living as a stealth pathogen[J]. Nat Rev Microbiol, 2016,14(12):744⁃759. DOI: 10.1038/nrmicro.2016.141. |
| [32] | Li K, Wang C, Lu H, et al. Regulatory T cells in peripheral blood and cerebrospinal fluid of syphilis patients with and without neurological involvement[J]. PLoS Negl Trop Dis, 2013,7(11):e2528. DOI: 10.1371/journal.pntd.0002528. |
| [33] | Yu Q, Cheng Y, Wang Y, et al. Aberrant humoral immune responses in neurosyphilis: CXCL13/CXCR5 play a pivotal role for B⁃cell recruitment to the cerebrospinal fluid[J]. J Infect Dis, 2017,216(5):534⁃544. DOI: 10.1093/infdis/jix233. |
| [34] | Shi M, Long F, Zou D, et al. Evaluation of cerebrospinal fluid Treponema pallidum particle agglutination assay titer for neurosyphilis diagnosis among HIV⁃negative syphilis patients[J]. Front Immunol, 2025,16:1572137. DOI: 10.3389/fimmu. 2025.1572137. |
| [35] | Reiber H. Flow rate of cerebrospinal fluid (CSF)⁃⁃a concept common to normal blood⁃CSF barrier function and to dysfunction in neurological diseases[J]. J Neurol Sci, 1994,122(2):189⁃203. DOI: 10.1016/0022⁃510x(94)90298⁃4. |
| [36] | Reiber H, Peter JB. Cerebrospinal fluid analysis: disease⁃related data patterns and evaluation programs[J]. J Neurol Sci, 2001,184(2):101⁃122. DOI: 10.1016/s0022⁃510x(00)00501⁃3. |
| [37] | Cerny EH, Hambie EA, Lee F, et al. Adenovirus ELISA for the evaluation of cerebrospinal fluid in patients with suspected neurosyphilis[J]. Am J Clin Pathol, 1985,84(4):505⁃508. DOI: 10.1093/ajcp/84.4.505. |
| [38] | van Eijk RV, Wolters EC, Tutuarima JA, et al. Effect of early and late syphilis on central nervous system: cerebrospinal fluid changes and neurological deficit[J]. Genitourin Med, 1987,63(2):77⁃82. DOI: 10.1136/sti.63.2.77. |
| [39] | Kissani N, Nafia S, Zahlane S, et al. Neurosyphilis: a series of 178 cases at the 3rd⁃level hospital of Marrakesh (Morocco)[J]. Eur J Clin Microbiol Infect Dis, 2021,40(10):2129⁃2135. DOI: 10.1007/s10096⁃021⁃04253⁃y. |
| [40] | Patel SS, Blum AL, Morgan RT, et al. Analysis of neurosyphilis imaging methods and treatment: a focused review[J]. Cureus, 2024,16(11):e72976. DOI: 10.7759/cureus.72976. |
| [41] | Choi EK, Kim YD, Jeong H, et al. Imaging characteristics of brain SPECT, PET, and MRI in neurosyphilis[J]. Nucl Med Mol Imaging, 2021,55(1):48⁃51. DOI: 10.1007/s13139⁃021⁃00684⁃9. |
| [42] | Wang C, Hu Z, Zheng X, et al. A new specimen for syphilis diagnosis: evidence by high loads of treponema pallidum DNA in Saliva[J]. Clin Infect Dis, 2021,73(9):e3250⁃e3258. DOI: 10.1093/cid/ciaa1613. |
| [43] | Gayet⁃Ageron A, Lautenschlager S, Ninet B, et al. Sensitivity, specificity and likelihood ratios of PCR in the diagnosis of syphilis: a systematic review and meta⁃analysis[J]. Sex Transm Infect, 2013,89(3):251⁃256. DOI: 10.1136/sextrans⁃2012⁃050622. |
| [44] | Vanhaecke C, Grange P, Benhaddou N, et al. Clinical and biological characteristics of 40 patients with neurosyphilis and evaluation of Treponema pallidum nested polymerase chain reaction in cerebrospinal fluid samples[J]. Clin Infect Dis, 2016,63(9):1180⁃1186. DOI: 10.1093/cid/ciw499. |
| [45] | Dai T, Qu R, Liu J, et al. Efficacy of doxycycline in the treatment of syphilis[J]. Antimicrob Agents Chemother, 2017,61(1)DOI: 10.1128/AAC.01092⁃16. |
| [46] | Yim CW, Flynn NM, Fitzgerald FT. Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis[J]. Antimicrob Agents Chemother, 1985,28(2):347⁃348. DOI: 10.1128/AAC.28.2.347. |
| [47] | Girometti N, Junejo MH, Nugent D, et al. Clinical and serological outcomes in patients treated with oral doxycycline for early neurosyphilis[J]. J Antimicrob Chemother, 2021,76(7):1916⁃1919. DOI: 10.1093/jac/dkab100. |
| [48] | Kingston M, French P, Higgins S, et al. UK national guidelines on the management of syphilis 2015[J]. Int J STD AIDS, 2016,27(6):421⁃446. DOI: 10.1177/0956462415624059. |
| [49] | Ozturk⁃Engin D, Erdem H, Hasbun R, et al. Predictors of unfavorable outcome in neurosyphilis: multicenter ID⁃IRI study[J]. Eur J Clin Microbiol Infect Dis, 2019,38(1):125⁃134. DOI: 10.1007/s10096⁃018⁃3403⁃7. |
| [50] | Wu YS, Lane HY, Lin CH. Donepezil improved cognitive deficits in a patient with neurosyphilis[J]. Clin Neuropharmacol, 2015,38(4):156⁃157. DOI: 10.1097/WNF.0000000000000094. |
| [51] | Chen WC, Wang HY, Chen PA, et al. Memantine rescues neurosyphilis⁃related schizophrenic⁃like features and cognitive deficit[J]. Clin Neuropharmacol, 2019,42(4):133⁃135. DOI: 10.1097/WNF.0000000000000347. |
| [52] | Hamill MM, Ghanem KG, Tuddenham S. State⁃of⁃the⁃art review: neurosyphilis[J]. Clin Infect Dis, 2024,78(5):e57⁃e68. DOI: 10.1093/cid/ciad437. |
| [53] | Mayoral V, Galvez R, Ferrándiz M, et al. Pregabalin vs. gabapentin in the treatment of neuropathic pain: a comprehensive systematic review and meta⁃analysis of effectiveness and safety[J]. Front Pain Res (Lausanne), 2024,5:1513597. DOI: 10.3389/fpain.2024.1513597. |
| [54] | Swisher CB, Doreswamy M, Gingrich KJ, et al. Phenytoin, levetiracetam, and pregabalin in the acute management of refractory status epilepticus in patients with brain tumors[J]. Neurocrit Care, 2012,16(1):109⁃113. DOI: 10.1007/s12028⁃011⁃9626⁃4. |
| [55] | Peng RR, Wu J, Zhao W, et al. An observational prospective study based on a large cohort of HIV⁃negative neurosyphilis patients with particular reference to the Jarisch⁃Herxheimer reaction[J]. Eur J Clin Microbiol Infect Dis, 2024,43(6):1073⁃1080. DOI: 10.1007/s10096⁃024⁃04810⁃1. |
| [56] | Public Health Agency of Canada. Syphilis guide: treatment and follow⁃up[EB/OL]. (2026⁃06⁃08)[2026⁃06⁃08]. https://www.canada.ca/en/public⁃health/services/infectious⁃diseases/sexual⁃health⁃sexually⁃transmitted⁃infections/canadian⁃guidelines/syphilis/treatment⁃follow⁃up.html. |
| [1] | Chinese Society of Dermatology, Chinese Society of Allergy, China Leprosy Association. Chinese guideline for the diagnosis and treatment of drug eruptions (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(9): 811-826. |
| [2] | China Dermatologist Association, Chinese Society of Dermatology, Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care, Dermatology Branch of China Alliance for Rare Diseases. Expert consensus on the long-term management of plaque psoriasis with biologic agents (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(9): 827-843. |
| [3] | Liang Yunsheng. Chronic hand eczema: current status and progress in clinical assessment [J]. Chinese Journal of Dermatology, 2026, 59(9): 850-855. |
| [4] | Tang Zhen¹, Liu Yuhang¹, Yang Ling², Hu Lingxue¹, He Zhijie¹, Cao Kai¹, Ding Shu¹. Value and features of reflectance confocal microscopy in the diagnosis and differential diagnosis of cutaneous lupus erythematosus [J]. Chinese Journal of Dermatology, 2026, 59(9): 873-880. |
| [5] | Expert Group on the “Chinese expert consensus on sirolimus in the treatment of Kaposiform hemangioendothelioma ( edition)”. Chinese expert consensus on sirolimus in the treatment of Kaposiform hemangioendothelioma (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(8): 728-737. |
| [6] | Chinese Society of Dermatology, China Dermatologist Association. Chinese guideline for the diagnosis and treatment of cutaneous squamous cell carcinoma (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(8): 703-716. |
| [7] | Writing Committee Expert Group on “Diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement ( edition)”. Diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(8): 717-727. |
| [8] | Li Yanhong, Jiang Kun, Wu Zhuoxuan, Zhang Jianlan, Fang Meizhen, Liu Shuting, Wang Linlin, Hu Lei, Zhou Xiaoyong, Chen Liuqing, Chen Jinbo. Analysis of 18 cases of cutaneous adverse reactions associated with programmed death-1 inhibitors [J]. Chinese Journal of Dermatology, 2026, 59(8): 783-787. |
| [9] | Wei Jin¹, Yan Huiwen¹, Zhang Jianzhong², Lun Wenhui¹. Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis complicated by HIV infection: a clinical observation of 10 cases [J]. Chinese Journal of Dermatology, 2026, 59(7): 671-674. |
| [10] | Wang Linlin, Cao Lijuan, Chen Liuqing, Li Dongsheng, Hu Yanyan. Efficacy and safety of hemoporfin-mediated photodynamic therapy for port-wine stains on the extremities: a retrospective analysis [J]. Chinese Journal of Dermatology, 2026, 59(7): 637-644. |
| [11] | Zhang Guolong, Zhao Zijun. Aminolevulinic acid-based photodynamic therapy for cutaneous squamous cell carcinoma: current status, challenges, and perspectives [J]. Chinese Journal of Dermatology, 2026, 59(7): 626-631. |
| [12] | Hu Yu, Lu Yan, Chen Kun, Gu Heng. Standardization, precision, and full-cycle management: interpretation of Specifications for the Management of Vitiligo Patients Undergoing Home Phototherapy [J]. Chinese Journal of Dermatology, 2026, 59(7): 632-636. |
| [13] | Dermatology Professional Committee of Chinese Research Hospital Society, China Dermatologist Association. Guideline for the clinical application of narrowband ultraviolet B phototherapy in dermatology (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(7): 595-610. |
| [14] | Photodynamic Therapy Research Cooperative Group, Chinese Society of Dermatology, Chinese Association of Rehabilitation Dermatology & Photodynamic Therapy, Photomedicine Therapeutic Equipment Group, Committee on Skin Disease and Cosmetic Dermatology, China Association of Medical Equipment. Guideline for the clinical application of aminolevulinic acid-based photodynamic therapy in the treatment of condyloma acuminatum (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(7): 611-618. |
| [15] | He Qing, Zhang Tao, Wang Xiuli, Gao Xinghua, Chen Hongduo, Liu Min, Qi Ruiqun. Biomarkers associated with malignant progression of actinic keratosis [J]. Chinese Journal of Dermatology, 2026, 59(7): 687-690. |
|